JDRF T1D Fund backs Protomer

Pasadena, California-based Protomer Technologies Inc, a biopharmaceutical company, has secured an investment from JDRF T1D Fund.

Pasadena, California-based Protomer Technologies Inc, a biopharmaceutical company, has secured an investment from JDRF T1D Fund. No financial terms were disclosed. This funding followed an initial equity investment in Protomer led by Eli Lilly and Company.

Source: Press Release